Contact UsInvestorsCareersMediaScienceContact Us
Science Leading Innovation, Collaboration Creating Future

Each of the breakthrough brings life-changing hope for patients.
Pfizer is committed to developing innovative drugs to meet the unmet needs of patients and make the impossible possible.

Home SciencePfizer China R&D Center

Pfizer China R&D Center (CRDC) is an important R&D hub of Pfizer in the world and the Asia Pacific region. It provides comprehensive support services for the development projects of the global product line. Over the past more than 30 years, Pfizer has introduced over 70 innovative products to China, including original drugs and vaccines. By 2025, Pfizer plans to achieve 24 breakthrough innovative products to apply for listing, and with the gradual implementation of the strategic goal of "80%&80%, we will try our best to realize the simultaneous application of product research and development in China to meet the health needs of Chinese patients at all stages of life.

China Research & Development Center


Pfizer China R&D Center was established on October 31, 2005, at Shanghai Zhangjiang High-tech Park Zone. It is one of the earliest and largest R & D centers set up by multinational pharmaceutical enterprises in China.


In 2010, Pfizer China R&D center Wuhan Branch was established, located in Wuhan Biolake Science and Technology Industrial Park.

Learn More
Pipeline Publicity of Medical RepresentativesPfizer Medical Information PfizerPro for Professionals Grant Seekers Media Terms of UseContact Us Business to Business © 2022 Pfizer Inc. All rights reserved 沪公网安备31010602006040 沪ICP备11000910号-2 药监批号(沪)-非经营性-2016-0003